Company description

Aspen Pharma is a leading specialty and branded multinational pharmaceutical company with a 20-year history • Well positioned in both emerging and developed markets • Markets and distributes products renowned for quality, efficacy and affordability • Core therapeutic categories include Regional Brands, Anaesthetics, Thrombosis and High Potency & Cytotoxics • Manufacturing capability covering a wide range of product types including injectables, oral solid dose, liquids, semi-solids, steriles, biologicals and active pharmaceutical ingredients • World class facilities with international approvals from global regulatory agencies  
Aspen Oss B.V. is a leading global supplier of Active Pharmaceutical Ingredients (APIs) to the global pharmaceutical industry with an almost 100-year history • Specialized in the manufacture of highly complex and highly potent APIs • Working from a deeply rooted and pro-active quality culture • Consistently delivering high product quality on schedule • Providing extensive support at all stages of your project: from proof of concept forward through registration and commercialization • Our facilities are successfully inspected and approved by international health authorities, such as the US FDA, Dutch Health Authorities, PMDA and others.      

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Alkaloids |API Contract Manufacturing |Generic Alkaloids More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 14C70 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 41H42 See our Exhibitor Profile   See full Exhibitor List

News about Aspen Oss B.V

Upgrading and expansion of HCG API manufacturing completed

5 Sep 2019

Upgrading and expansion of HCG API manufacturing completed

Aspen Oss has completed a major upgrading and expansion project at its hCG manufacturing facility in Boxtel, the Netherlands; an extensive project that was started in 2017.

Read more

29 Jul 2019

Successful ANVISA inspection on Heparin Sodium

The Brazilian authorities – ANVISA – have inspected the Aspen Oss facilities with a special focus on Heparin Sodium.

Read more
Aspen Oss B.V

Contact information




View all contact information